OUR KNOW-HOW
Comparative Medicine Studies of owned-Dogs with spontaneous cancers, or chronic diseases, as natural animal models for assessment of drug candidates under development for Human Health.
OBJECTIVES
Getting access to more predictive data of Human Cancers (Efficacy, MoA, Immune-Monitoring, Pk/Pd, Therapeutic Scheme, specific Anti-Metastatic effect, new Indication opportunities…) for a more relevant development in clinic in Human.
DRUG
CANDIDATE STAGES
Late Preclinical stage & early Clinical stage
Main cancers affecting owned-Dogs: NH Lymphoma, Melanoma, Soft tissues sarcoma, Head & Neck Carcinoma, Osteosarcoma, Urogenital tumors, Mammary tumors, Brain & Spinal cord tumors, Prostatic tumor…
Others therapeutic fields : Inflammation, Neurology, Pain, Dermatology, Cardiology, Ophthalmology, Antibiotic resistance…
HIGH LEVEL
TECHNICAL PLATFORM
Imaging (CT-scan, MRI, Scintigraphy), Radiation therapy (High & Low energy), Surgery, Nuclear medicine capabilities, IHC Ventana Discovery capabilities (cross-reactivity step if required before going to Dog patients)
Large team of specialized veterinarians (Oncologists, Cardiologist, Internal Medicine specialists, Imaging specialists, Pathologists, Surgeons, Radiation oncology specialist…) thanks to a network of 25 vet clinical centers across Europe.
